← Eichor
Study identifier: NCT02747888 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Hereditary Risk Factors for Thyroid Cancer

Condition: Thyroid Cancer  ·  Sponsor: Dana-Farber Cancer Institute

PhaseNA
Planned participants250
Who can joinAll sexes, N/A to no upper limit
Healthy volunteersYes

About this study

Thyroid cancers can occur sporadically, but can also be found as tumors that cluster in families with other cancers or genetic syndromes. Researchers are studying thyroid cancer in children and families, with a particular interest in understanding genes and other factors that may put individuals at risk for developing thyroid cancer and thyroid nodules. * In this study, family and medical history information is collected alongside a blood or saliva sample for genetic studies. * Individuals with a past or present childhood thyroid cancer/nodule or a thyroid cancer suspected to be inherited in their family are invited to participate.

This description comes directly from the study's public registry record.

Talk to the study team

Junne Kamihara, MD, PhD  ·  617.632.3044  ·  junne_kamihara@dfci.harvard.edu

Sarah Hunt, MPH  ·  sarah_hunt@dfci.harvard.edu

Always discuss trial participation with your own doctor first.

Locations (1)

Dana Farber Cancer InstituteBoston, Massachusetts, United StatesRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT02747888